학술논문

A long-acting formulation of the integrase inhibitor raltegravir protects humanized BLT mice from repeated high-dose vaginal HIV challenges
Document Type
Article
Source
In: Journal of Antimicrobial Chemotherapy. (Journal of Antimicrobial Chemotherapy, 13 June 2016, 71(6):1586-1596)
Subject
Language
English
ISSN
14602091
03057453